Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems.

J. C. Pickup, R. S. Sherwin, W. V. Tamborlane, R. A. Rizza, F. J. Service

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

As part of a randomized, prospective trial in subjects with insulin-dependent diabetes assigned to either continuous subcutaneous insulin infusion (CSII) or to their unchanged conventional insulin treatment (CIT) for 8 mo, patients completed questionnaires dealing with general responses and clinical and technological problems. Although there was no significant difference between treatment groups with respect to the number of patients experiencing severe hypoglycemia (i.e., requiring intravenous glucose or intramuscular glucagon injection), there were nine episodes in six patients during CSII compared with one episode during CIT. Diabetic ketoacidosis occurred significantly more often in the CSII group (nine episodes in eight patients) than in the CIT group (no episodes). A number of CSII-related failures occurred, including omission of premeal bolus, needle dislodgement, pump accidentally turned off, and leakage at the infusion site. At 8 mo, 85% of CSII-treated patients wished to continue indefinitely on the pump, and almost all would continue with self-monitoring of blood glucose even if they stopped CSII.

Original languageEnglish (US)
Pages (from-to)37-41
Number of pages5
JournalDiabetes
Volume34 Suppl 3
StatePublished - Aug 1985
Externally publishedYes

Fingerprint

Multicenter Studies
Subcutaneous Infusions
Insulin
Therapeutics
Blood Glucose Self-Monitoring
Diabetic Ketoacidosis
Intramuscular Injections
Glucagon
Hypoglycemia
Needles
Glucose

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems. / Pickup, J. C.; Sherwin, R. S.; Tamborlane, W. V.; Rizza, R. A.; Service, F. J.

In: Diabetes, Vol. 34 Suppl 3, 08.1985, p. 37-41.

Research output: Contribution to journalArticle

Pickup, J. C. ; Sherwin, R. S. ; Tamborlane, W. V. ; Rizza, R. A. ; Service, F. J. / Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems. In: Diabetes. 1985 ; Vol. 34 Suppl 3. pp. 37-41.
@article{4e0ad7a6819c4890a74f68156641ae65,
title = "Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems.",
abstract = "As part of a randomized, prospective trial in subjects with insulin-dependent diabetes assigned to either continuous subcutaneous insulin infusion (CSII) or to their unchanged conventional insulin treatment (CIT) for 8 mo, patients completed questionnaires dealing with general responses and clinical and technological problems. Although there was no significant difference between treatment groups with respect to the number of patients experiencing severe hypoglycemia (i.e., requiring intravenous glucose or intramuscular glucagon injection), there were nine episodes in six patients during CSII compared with one episode during CIT. Diabetic ketoacidosis occurred significantly more often in the CSII group (nine episodes in eight patients) than in the CIT group (no episodes). A number of CSII-related failures occurred, including omission of premeal bolus, needle dislodgement, pump accidentally turned off, and leakage at the infusion site. At 8 mo, 85{\%} of CSII-treated patients wished to continue indefinitely on the pump, and almost all would continue with self-monitoring of blood glucose even if they stopped CSII.",
author = "Pickup, {J. C.} and Sherwin, {R. S.} and Tamborlane, {W. V.} and Rizza, {R. A.} and Service, {F. J.}",
year = "1985",
month = "8",
language = "English (US)",
volume = "34 Suppl 3",
pages = "37--41",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",

}

TY - JOUR

T1 - Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems.

AU - Pickup, J. C.

AU - Sherwin, R. S.

AU - Tamborlane, W. V.

AU - Rizza, R. A.

AU - Service, F. J.

PY - 1985/8

Y1 - 1985/8

N2 - As part of a randomized, prospective trial in subjects with insulin-dependent diabetes assigned to either continuous subcutaneous insulin infusion (CSII) or to their unchanged conventional insulin treatment (CIT) for 8 mo, patients completed questionnaires dealing with general responses and clinical and technological problems. Although there was no significant difference between treatment groups with respect to the number of patients experiencing severe hypoglycemia (i.e., requiring intravenous glucose or intramuscular glucagon injection), there were nine episodes in six patients during CSII compared with one episode during CIT. Diabetic ketoacidosis occurred significantly more often in the CSII group (nine episodes in eight patients) than in the CIT group (no episodes). A number of CSII-related failures occurred, including omission of premeal bolus, needle dislodgement, pump accidentally turned off, and leakage at the infusion site. At 8 mo, 85% of CSII-treated patients wished to continue indefinitely on the pump, and almost all would continue with self-monitoring of blood glucose even if they stopped CSII.

AB - As part of a randomized, prospective trial in subjects with insulin-dependent diabetes assigned to either continuous subcutaneous insulin infusion (CSII) or to their unchanged conventional insulin treatment (CIT) for 8 mo, patients completed questionnaires dealing with general responses and clinical and technological problems. Although there was no significant difference between treatment groups with respect to the number of patients experiencing severe hypoglycemia (i.e., requiring intravenous glucose or intramuscular glucagon injection), there were nine episodes in six patients during CSII compared with one episode during CIT. Diabetic ketoacidosis occurred significantly more often in the CSII group (nine episodes in eight patients) than in the CIT group (no episodes). A number of CSII-related failures occurred, including omission of premeal bolus, needle dislodgement, pump accidentally turned off, and leakage at the infusion site. At 8 mo, 85% of CSII-treated patients wished to continue indefinitely on the pump, and almost all would continue with self-monitoring of blood glucose even if they stopped CSII.

UR - http://www.scopus.com/inward/record.url?scp=0022113998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022113998&partnerID=8YFLogxK

M3 - Article

C2 - 3894127

AN - SCOPUS:0022113998

VL - 34 Suppl 3

SP - 37

EP - 41

JO - Diabetes

JF - Diabetes

SN - 0012-1797

ER -